Much shorter radiation treatment found to be safe, effective for people with soft tissue sarcoma
(University of California - Los Angeles Health Sciences) A new study led by researchers at UCLA found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 13, 2020 Category: Cancer & Oncology Source Type: news
Tazverik Approved to Treat Metastatic, Locally Advanced Epithelioid Sarcoma
Approval marks the first for a drug to treat this rare soft tissue sarcoma (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 25, 2020 Category: Cancer & Oncology Tags: Oncology, Pharmacy, FDA Approvals, Source Type: news
B cells: New allies in sarcoma immunotherapy?
(INSERM (Institut national de la sant é et de la recherche m é dicale)) How can we improve and better personalize the treatment of soft tissue sarcomas, these particularly resistant and aggressive forms of cancer? An international team led by Wolf Herv é Fridman with researchers from Inserm, Sorbonne Universit é and Universit é de Paris, has shown that B cells also play a major role in predicting of patient's response to immunotherapy. Their findings, to be published in Nature, pave the way for the personalization of treatments for patients with soft tissue sarcomas. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 15, 2020 Category: International Medicine & Public Health Source Type: news
Public Insurance Tied to Lower Cancer Survival in Young Patients
FRIDAY, Dec. 27, 2019 -- Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 15 in Cancer Medicine.
Neela L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 27, 2019 Category: Pharmaceuticals Source Type: news
Markedly Elevated Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma Markedly Elevated Sarcoma Risk in Long-Term Survivors of Hereditary Retinoblastoma
The risk of bone and soft-tissue sarcoma is markedly elevated in long-term survivors of hereditary retinoblastoma treated with radiation, researchers report.Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - November 26, 2019 Category: Orthopaedics Tags: Hematology-Oncology News Source Type: news
Turning key metabolic process back on could make sarcoma more susceptible to treatment
(University of Pennsylvania School of Medicine) Soft tissue sarcoma cells stop a key metabolic process which allows them to multiply and spread, and so restarting that process could leave these cancers vulnerable to a variety of treatments (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - November 26, 2019 Category: Biology Source Type: news
Neoadjuvant Chemotherapy for Primary Sarcoma of the Breast Neoadjuvant Chemotherapy for Primary Sarcoma of the Breast
This case suggests that breast sarcomas could be treated in the same way as other soft tissue sarcomas in terms of adjuvant chemotherapy.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 20, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
Chest X-Ray Favored for Lung Surveillance After High-Grade Soft Tissue Sarcoma Chest X-Ray Favored for Lung Surveillance After High-Grade Soft Tissue Sarcoma
Chest x-ray may be better than chest CT for lung surveillance after resection of high-grade soft-tissue sarcoma, according to findings from the U.S. Sarcoma Collaborative (USSC).Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - September 3, 2019 Category: Radiology Tags: Hematology-Oncology News Source Type: news
Complete Tumor Removal in Dogs Cuts Risk of Cancer's Return: Study
MONDAY, May 20, 2019 -- In dogs, soft tissue sarcoma is a group of malignant cancers that come from skin or connective tissue. Now, a new research review says when a tumor is completely removed, the risk of cancer returning is cut by nearly... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 20, 2019 Category: General Medicine Source Type: news
Cancer-stricken woman, 27, desperately tries to raise £500,000 for experimental treatment in the US
Hope Stringer, from Essex, is facing soft tissue sarcoma for the third time in five years. She was told the cancer had returned and spread weeks after she became engaged. (Source: the Mail online | Health)
Source: the Mail online | Health - February 11, 2019 Category: Consumer Health News Source Type: news
Olaratumab for Sarcoma Under Review After Negative Trial Olaratumab for Sarcoma Under Review After Negative Trial
The product has been used in combination with doxorubicin in patients with soft tissue sarcoma, but negative results from a confirmatory trial put its future in question.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
After winning accelerated approval, Lilly ’s cancer drug fails in study
An Eli Lilly treatment for advanced soft-tissue sarcoma missed the mark in a phase 3 study and will no longer be prescribed. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - January 21, 2019 Category: Pharmaceuticals Source Type: news
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Study did not meet the primary endpoints of overall survival (OS) in the full study population or in the leiomyosarcoma (LMS) sub-population; there was no difference in survival between the study arms for either population.
There were no new safety sign... Biopharmaceuticals, Oncology Eli Lilly, LARTRUVO, olaratumab, soft tissue sarcoma, leiomyosarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2019 Category: Pharmaceuticals Source Type: news
